ResMed Gross Margin 2010-2023 | RMD
Current and historical gross margin for ResMed (RMD) over the last 10 years. The current gross profit margin for ResMed as of December 31, 2023 is %.
| ResMed Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $4.50B | $2.48B | 55.11% |
| 2023-09-30 | $4.38B | $2.42B | 55.20% |
| 2023-06-30 | $4.22B | $2.36B | 55.79% |
| 2023-03-31 | $4.02B | $2.26B | 56.32% |
| 2022-12-31 | $3.76B | $2.14B | 56.72% |
| 2022-09-30 | $3.63B | $2.06B | 56.80% |
| 2022-06-30 | $3.58B | $2.02B | 56.55% |
| 2022-03-31 | $3.54B | $1.99B | 56.27% |
| 2021-12-31 | $3.44B | $1.95B | 56.56% |
| 2021-09-30 | $3.35B | $1.91B | 56.91% |
| 2021-06-30 | $3.20B | $1.84B | 57.52% |
| 2021-03-31 | $3.09B | $1.80B | 58.14% |
| 2020-12-31 | $3.09B | $1.80B | 58.23% |
| 2020-09-30 | $3.03B | $1.77B | 58.31% |
| 2020-06-30 | $2.96B | $1.72B | 58.12% |
| 2020-03-31 | $2.89B | $1.66B | 57.56% |
| 2019-12-31 | $2.78B | $1.60B | 57.29% |
| 2019-09-30 | $2.70B | $1.54B | 57.17% |
| 2019-06-30 | $2.61B | $1.49B | 57.33% |
| 2019-03-31 | $2.53B | $1.43B | 56.79% |
| 2018-12-31 | $2.46B | $1.40B | 56.90% |
| 2018-09-30 | $2.41B | $1.37B | 57.05% |
| 2018-06-30 | $2.34B | $1.34B | 57.03% |
| 2018-03-31 | $2.27B | $1.32B | 58.22% |
| 2017-12-31 | $2.20B | $1.28B | 58.29% |
| 2017-09-30 | $2.13B | $1.24B | 58.31% |
| 2017-06-30 | $2.07B | $1.20B | 58.18% |
| 2017-03-31 | $2.03B | $1.18B | 58.14% |
| 2016-12-31 | $1.97B | $1.14B | 57.88% |
| 2016-09-30 | $1.89B | $1.10B | 57.95% |
| 2016-06-30 | $1.84B | $1.07B | 57.99% |
| 2016-03-31 | $1.77B | $1.03B | 57.78% |
| 2015-12-31 | $1.74B | $1.02B | 58.32% |
| 2015-09-30 | $1.71B | $1.01B | 59.18% |
| 2015-06-30 | $1.68B | $1.01B | 60.19% |
| 2015-03-31 | $1.64B | $1.01B | 61.71% |
| 2014-12-31 | $1.62B | $1.01B | 62.69% |
| 2014-09-30 | $1.58B | $1.00B | 63.35% |
| 2014-06-30 | $1.56B | $0.99B | 63.67% |
| 2014-03-31 | $1.56B | $0.99B | 63.60% |
| 2013-12-31 | $1.54B | $0.98B | 63.34% |
| 2013-09-30 | $1.53B | $0.96B | 62.58% |
| 2013-06-30 | $1.52B | $0.94B | 62.07% |
| 2013-03-31 | $1.47B | $0.91B | 61.58% |
| 2012-12-31 | $1.44B | $0.88B | 61.06% |
| 2012-09-30 | $1.39B | $0.84B | 60.55% |
| 2012-06-30 | $1.37B | $0.82B | 59.90% |
| 2012-03-31 | $1.34B | $0.79B | 59.22% |
| 2011-12-31 | $1.30B | $0.77B | 58.79% |
| 2011-09-30 | $1.28B | $0.75B | 59.01% |
| 2011-06-30 | $1.24B | $0.74B | 59.69% |
| 2011-03-31 | $1.19B | $0.72B | 60.18% |
| 2010-12-31 | $1.16B | $0.70B | 60.57% |
| 2010-09-30 | $1.13B | $0.68B | 60.28% |
| 2010-06-30 | $1.09B | $0.66B | 60.02% |
| 2010-03-31 | $1.05B | $0.64B | 60.59% |
| 2009-12-31 | $1.00B | $0.61B | 60.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $27.097B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Stryker (SYK) | United States | $127.423B | 31.59 |
| Medtronic (MDT) | Ireland | $107.939B | 15.28 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Baxter (BAX) | United States | $20.831B | 15.19 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |